A venture capital firm backed by Chinese internet firm Baidu is in talks to sell a portfolio of stakes in a range of U.S. startups, including artificial…
/PRNewswire/ Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable.
Degron Raises $22 Million to Advance Molecular-Glue-Based Protein Degradation Platform globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.